CME Group’s lawsuit against the U.S. Commodity Futures Trading Commission over the approval of crypto perpetual futures has sparked criticism from industry observers, with Hyperliquid Policy Center chief Jake Chervinsky labeling the move a “shocking miscalculation.”
Legal Challenge and Industry Reaction
On June 19, Chervinsky posted on X that CME’s filing against the CFTC and Chairman Michael Selig reveals a “petty incumbent monopolist afraid of competition.” He argued that the exchange is leveraging litigation to shield its dominance in the derivatives market. The Hyperliquid Policy Center further described the lawsuit as an unforced error that could stifle emerging blockchain‑based products.
Regulatory Classification Dispute
CME contends that the CFTC incorrectly labeled crypto perpetual contracts as futures rather than swaps, a distinction governed by the Dodd‑Frank Act. The exchange maintains that the proper classification would limit regulatory oversight and open the market to broader participation. This legal stance aims to reshape how investors access crypto derivatives in the United States.
Market Share and Trading Volume
Better Markets data cited by Hyperliquid indicates that CME controls roughly 92 % of U.S. exchange‑traded derivatives volume, underscoring its leverage over the market. Since the introduction of regulated perpetual futures, trading activity has surpassed $1 billion, attracting both institutional investors and retail traders. Critics warn that CME’s actions could hinder competition and limit options for crypto market participants.